Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Meenakshi Hegde(Baylor College of Medicine), Shoba A. Navai(Houston Methodist), Christopher DeRenzo(Houston Methodist), Sujith K. Joseph(Houston Methodist), Khaled Sanber(Houston Methodist), Meng‐Fen Wu(Baylor College of Medicine), Ahmed Z. Gad(Houston Methodist), Katherine A. Janeway(Boston Children's Hospital), Matthew Campbell(Houston Methodist), Dolores Mullikin(Houston Methodist), Zeid Nawas(Houston Methodist), Catherine Robertson(Houston Methodist), Pretty Mathew(Houston Methodist), Huimin Zhang(Houston Methodist), Birju Mehta(Houston Methodist), Raksha R. Bhat(Houston Methodist), Angela M. Major(Baylor College of Medicine), Ankita Shree(Houston Methodist), Claudia Gerken(Houston Methodist), Mamta Kalra(Houston Methodist), Rikhia Chakraborty(Baylor College of Medicine), Sachin G. Thakkar(Houston Methodist), Olga Dakhova(Houston Methodist), Vita S. Salsman(Houston Methodist), Bambi Grilley(Houston Methodist), Natalia Lapteva(Houston Methodist), Adrian P. Gee(Houston Methodist), Gianpietro Dotti(University of North Carolina at Chapel Hill), Riyue Bao(University of Pittsburgh), Ahmed Hamed Salem(Ain Shams University), Tao Wang(Baylor College of Medicine), Malcolm K. Brenner(Houston Methodist), Helen E. Heslop(Houston Methodist), Winfried S. Wels(Goethe University Frankfurt), John Hicks(Baylor College of Medicine), Stephen Gottschalk(Houston Methodist), Nabil Ahmed(Houston Methodist)
Nature Cancer
April 24, 2024
Cited by 75Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis